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Protocol
AbstrACt
Introduction Increasing antibiotic resistance (ABR) 
in low-income and middle-income countries such as 
Bangladesh presents a major health threat. However, 
assessing the scale of the health risk is problematic in the 
absence of reliable data on the community prevalence of 
antibiotic-resistant bacteria. We describe the protocol for a 
small-scale integrated surveillance programme that aims 
to quantify the prevalence of colonisation with antibiotic-
resistant bacteria and concentrations of antibiotic-resistant 
genes from a ‘One Health’ perspective. The holistic 
assessment of ABR in humans, animals and within the 
environment in urban and rural Bangladesh will generate 
comprehensive data to inform human health risk.
Methods and analysis The study design focuses on three 
exposure-relevant sites where there is enhanced potential 
for transmission of ABR between humans, animals and 
the environment: (1) rural poultry-owning households, (2) 
commercial poultry farms and (3) urban live-bird markets. 
The comparison of ABR prevalence in human groups with 
high and low exposure to farming and poultry will enable 
us to test the hypothesis that ABR bacteria and genes from 
the environment and food-producing animals are potential 
sources of transmission to humans. Escherichia coli is 
used as an ABR indicator organism due to its widespread 
environmental presence and colonisation in both the 
human and animal gastrointestinal tract.
Ethics and dissemination The study has been approved 
by the Institutional Review Board of the International 
Centre for Diarrhoeal Disease Research, Bangladesh, and 
Loughborough University Ethics Committee. Data for the 
project will be stored on the open access repository of the 
Centre for Ecology and Hydrology, Natural Environment 
Research Council. The results of this study will be 
published in peer-reviewed journals and presented at 
national and international conferences.
IntroduCtIon 
Antibiotic resistance (ABR) has been widely 
recognised as an emerging threat to human 
health and a global research priority for 
capacity development and public health 
campaigns in clinical and community 
settings.1 Antimicrobial resistance is seen as 
a ‘One Health’ challenge.1 That is, efforts 
are needed to tackle the problem of ABR in 
all three domains of humans, animals and in 
the wider environment in order to achieve 
optimal human health.2 
The natural environment is acknowledged 
as an important reservoir of antibiotic-resis-
tant bacteria, with anthropogenic activities 
such as agriculture, antibiotic residues and 
wastewater disposal potentially enhancing the 
horizontal transfer of resistant genes.3 4 Genes 
for ABR can survive in the environment, 
collectively known as the ‘resistome’, and 
the exchange of genetic material encoding 
for antimicrobial resistance can take place 
through mobile genetic elements such as plas-
mids via conjugation and other mechanisms 
in environmental compartments.5 Antimi-
crobials have been shown also to induce the 
transfer of resistance determinants between 
micro-organisms.6 These processes may 
be accelerated by the presence of environ-
mental contaminants or pollutants such as 
heavy metals, antibiotic residues or biocides.7 
However, it is not yet known to what extent 
these environmental sources of ABR may be 
transmitted to humans. There is therefore a 
strengths and limitations of this study
 ► We present a study protocol focused on integrated 
surveillance of antibiotic resistance in urban and ru-
ral Bangladesh using a One Health approach.
 ► Assessment of the human, poultry and environmen-
tal prevalence of antibiotic-resistant Escherichia coli 
will identify potential hot spots for its  transmission 
in Bangladesh.
 ► Seasonal and spatial variation on the occurrence of 
antibiotic-resistant bacteria in humans, poultry and 
the wider environment will be assessed.
 ► The two regions included in the study may not be 
typical of all regions within Bangladesh.
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pressing need for research to quantify the extent of trans-
mission of clinically relevant ABR bacteria from the envi-
ronment to humans.8
Resistance to third-generation cephalosporins is 
increasing as bacteria acquire the ability to produce 
extended-spectrum beta-lactamases (ESBLs). The preva-
lence of human colonisation with ESBL-producing Esch-
erichia coli is estimated to be around 14% globally, with 
rates as high as 22% in Asia and Sub-Saharan Africa.9 Of 
greater concern, however, is the emergence and spread of 
carbapenem resistance among clinically relevant bacteria 
via genes such as New Delhi Metallo-β-lactamase-1 
(NDM-1) and colistin resistance via mcr-1 gene.10–12 The 
detection of these genes in humans, animals and the 
environment has led to heightened concern regarding 
the environment as a major transmission route for anti-
microbial resistance to humans.10 NDM-1 has been iden-
tified in Bangladesh since 2010,13 after the first detection 
and rapid spread across India and Pakistan from 2008 
onwards.14 15 Municipal water supplies in Dhaka are 
known to carry high levels of sewage-derived bacteria.16 
Around 36% of E. coli isolates from tap water samples in 
Dhaka city were reported to be multidrug-resistant and 
26% of these were positive for ESBLs, posing a serious 
threat to public health.16 Drinking water contamina-
tion is also common in rural areas of Bangladesh; 59% 
of drinking water samples for children that were stored 
or directly obtained mostly from tubewells were positive 
for E. coli faecal contamination17 but were not tested for 
resistant phenotypes. Prospective sampling indicated 
that ingestion of contaminated water led to subsequent 
episodes of diarrhoea among children.17 Approximately 
3.5% of Gram-negative clinical isolates in Bangladesh are 
NDM-1-producing,18 and faecal carriage of NDM-1-pro-
ducing bacteria has been demonstrated among patients 
with diarrhoea.13 19
The physical and social environment in Bangladesh 
favours the rapid spread of ABR with high-density popu-
lations, lack of clean drinking water and poor sanitation 
infrastructure. Widespread faecal contamination in water 
and soil, as well as human hands and food, has been 
demonstrated in microbiological studies in Bangladesh.20 
The availability of inexpensive antimicrobials from 
over-the-counter suppliers leads to inappropriate use of 
antibiotics.21 The release of antimicrobials into the envi-
ronment through drug manufacturing and poor waste 
disposal processes adds further complexities to the path-
ways for the selection and spread of resistance in the envi-
ronment.22 In Bangladesh, a high prevalence of blaNDM-1 
genes has been found in hospital wastewater compared 
with community wastewater in the city of Dhaka, high-
lighting anthropogenic influences on ABR prevalence.23
As well as the risk factors for ABR associated with 
water supply, sanitation and infrastructure, the environ-
mental risks of ABR transmission are likely to change with 
seasonal and rainfall variability, and concomitant changes 
in human exposure risk to contaminated surface and 
drinking water.20 Seasonal behaviours may also change 
transmission dynamics. Ahammad et al24 found high 
concentrations of blaNDM-1 in the Yamuna River in Delhi 
and increased concentration of blaNDM-1 in rural river water 
and sediment samples following the mass pilgrimage of 
visitors from New Delhi to a holy site in Rishikesh-Ha-
ridwar, North India.
We have identified the following gaps in knowledge 
surrounding the prevalence and transmission of ABR 
genes and bacteria at the community level: (1) an absence 
of contemporaneous sampling of ABR in humans, animals 
and the wider environment in low-income and middle-in-
come countries such as Bangladesh; (2) a lack of quan-
titative measures of ABR bacteria (E. coli) and resistance 
genes in potential hot spots for transmission at an appro-
priate spatial and temporal scale; (3) an absence of base-
line data from rural locations to establish whether ABR 
prevalence rates are similar to those observed in urban 
Dhaka; (4) a lack of knowledge regarding the seasonal 
dynamics of resistant bacteria and gene concentrations 
in different environmental compartments; and (5) a lack 
of comparative data of human carriage of resistant genes 
in groups with high and low exposure to contaminated 
outdoor environments.
The specific objectives of the research are as follows:
1. To ascertain the prevalence and concentration of an-
tibiotic-resistant bacteria (E. coli) and resistance genes 
for ESBLs and carbapenemases (blaCTX-M-1 and blaNDM-1) 
among humans, animal reservoirs (poultry) and dif-
ferent environmental compartments (water, soil and 
waste) in Bangladesh.
2. To identify the selective drivers of ABR in three ex-
posure-relevant outdoor environments: urban poultry 
markets, commercial poultry farms and rural villages.
3. To assess the transfer of resistance within and between 
microbial communities by comparing ABR carriage 
rates in humans with high and low exposure to envi-
ronmental and animal reservoirs of ABR genes.
4. To assess the anthropogenic influences on ABR in the 
natural environment through ethnographic research 
among poultry farmers, market sellers and village 
poultry owners.
To explore the transmission of ABR between the 
outdoor environment and human and animal hosts, we 
consider poultry as one of the key drivers of ABR selec-
tion through faecal shedding of ABR bacteria. Poultry 
have high rates of faecal carriage of ABR bacteria; they 
are the most common domestic animal in rural areas of 
Bangladesh,25 as well as being reared in urban slums in 
Bangladesh.26 Among poultry owners in rural Bangla-
desh, 57% reported using over-the-counter antibiotics for 
their poultry in the last 6 months, 50% reported sharing 
their sleeping area with poultry and 61% used poultry 
faeces as fertiliser.25 The rapid expansion of commercial 
poultry farming in periurban areas carries risks for ABR, 
with high rates of antibiotic use for growth promotion 
and prophylactic treatment and poor regulation of waste 
disposal.27 28 Fresh food and poultry markets in Dhaka city 
are the largest outlets of commercial poultry where birds 
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are slaughtered and processed on site with no regulated 
solid and liquid waste disposal system.29 Faecal wastes 
produced within commercial farms and urban markets 
are mostly disposed into the environment through direct 
washout.29
MEthods And AnAlysIs
The conceptual framework for the study design and the 
sampling strategy is shown in figure 1. The study will 
generate robust data through a sampling framework 
targeting three distinct outdoor environments with a high 
potential for ABR transmission: (1) urban live poultry 
markets in high-density residential areas, (2) commer-
cial poultry farms in rural sites serving the urban retail 
market, and (3) rural villages with traditional animal 
husbandry and backyard poultry.
E. coli will be investigated as an indicator organism due 
to its reliability, ease of culturing, affordability and rele-
vance as a contributor to both diarrhoeal disease (eg, 
diarrhoeagenic strains) and ABR (eg, multidrug-resistant 
strains). E. coli has been listed by the WHO as a critically 
important organism for antimicrobial resistance.30 The 
bacterium is a normal resident of the intestinal tract of 
both human and animals, as well as the environment, but 
pathogenic strains give rise to clinical diseases in both 
hosts.31 Hence, E. coli is widely used in studies of the envi-
ronmental transmission of ABR, particularly for commu-
nity-acquired resistance using a One Health approach.4
The geospatial nature of the transfer of resistance genes 
will be assessed through geospatial mapping of concentra-
tions of resistant genes and bacteria in upstream localities 
(water supply), sites close to contamination (source) and 
downstream (surface waters, soil and solid waste) (see 
figure 1) at each location using geographical information 
system software (ArcGIS).
Contemporaneous measures will be taken of healthy 
humans and animal faecal samples. Temporal variability 
will be assessed by comparison of resistant E. coli bacteria 
and gene concentrations (blaNDM-1 and blaCTX-M-1) between 
the dry and wet seasons in environmental compartments 
as well as in the human and animal species.
Ethnographic data will be collected regarding customs 
and practices of market poultry sellers, slaughterers, 
farm workers and village households that own domestic 
Figure 1 Sampling framework showing the three study sites in relation to the research objectives.  In each site, one sampling 
round will be conducted in the dry season (n=20 markets; n=20 farms; n=20 households) and another sampling round in the wet 
season (an additional n=20 markets; n=20 farms; n=20 households).
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chickens. Initially, formative observations will be carried 
out by a trained field team led by an anthropologist, 
followed by indepth interviews with individuals who 
work in poultry markets, commercial farms (farmers 
and suppliers of chicks and feed) or who own backyard/
domestic poultry (12–15 interviews of 30–40 min dura-
tion). The formative observations and indepth interviews 
will identify key behaviours relating to human–poultry 
interactions in each environmental location. Following 
the formative observations and indepth interviews, 
structured observations will be performed to measure 
behaviours leading to human exposure to poultry and 
environmental sources of potential contamination. This 
will yield quantitative data relating to poultry handling, 
hand washing before and after handling poultry, poultry 
meat and fresh food preparation, water use, and the 
disposal of solid waste material (poultry faeces and 
carcasses/feathers). This information, alongside qualita-
tive data from indepth interviews, will provide contextual 
data on the human behaviours and practices that may 
increase environmental contamination and/or increase 
human exposure to contaminated environments and 
animals.
An interviewer-administered survey of participants will 
document common practices of domestic (rural) and 
commercial poultry holders (farmers and market sellers). 
Domestic and commercial poultry owners and market 
sellers will be questioned about antimicrobial additives 
in feed, purchase of antimicrobial treatment for animals, 
and the personal purchase and use of antibiotics for 
themselves.
selection and recruitment of study participants
Human participants will be recruited to take part in the 
study on a voluntary basis and will be provided with infor-
mation about the study. Only those who volunteer and 
provide their written informed consent will take part in 
surveys and provide a faecal sample. The sampling within 
live poultry markets will start from the centre of a market, 
omitting the first 10 eligible stalls, approaching the next 
eligible stall and asking the owner to participate. In this 
way, stallholders with high exposure and their poultry 
will be recruited. The low exposure group will comprise 
stallholders without animal produce (eg, those selling 
grocery items/fruits/vegetables) in the same markets. 
The same geographical sampling strategy will be used 
for household selection in villages to attain 10 poul-
try-owning and 10 non-poultry-owning households. Farms 
will be selected from a list registered with the Department 
of Livestock Services and access requested through the 
Upazila Livestock Officer. A low-risk comparison group of 
non-farm workers will be recruited from the same residen-
tial area as the farm workers. A team of four fieldworkers 
will collect samples and data in the wet (monsoon) and 
dry seasons. Supervision and coordination of fieldwork 
and laboratory analysis of samples will be carried out by 
an experienced research investigator. Data collection 
commenced in March 2017 and is ongoing.
Patient and public involvement
As this was a study of healthy adults in community settings, 
a patient group was not involved in the study design or 
research protocol. However, the study team consulted 
local community representatives prior to commencing 
fieldwork to discuss the research, consulted with the main 
local hospital, and liaised with local government staff in 
livestock services to discuss working with the poultry farm 
workers, as well as obtain a list of registered commercial 
farms. This did not result in any direct changes to the 
protocol but confirmed that the intended methods and 
approaches were appropriate. Feedback on the research 
findings will be provided through open meetings in the 
communities, as well as sharing with relevant stakeholders 
and users of the research as part of the planned dissemi-
nation activities.
sample collection for laboratory analysis
Poultry caecal samples
Live chickens will be collected from rural households, 
poultry farms and live-bird markets, and slaughtered. 
After defeathering, the whole carcass will be placed in a 
sterile zipper bag. After transportation to the laboratory 
under a cold chain (4°C–8°C), caecal samples will be 
collected aseptically from the dissected whole carcass.
Poultry faeces samples
Poultry litter samples will be collected from three 
different areas of the bird cage/container, floor (in cases 
where birds are kept in a confined area and not in a cage) 
or grounds of a compound for free-ranging animals, and 
pooled in a sterile plastic bag and mixed thoroughly.
Solid waste samples
Solid waste samples will be collected from the munic-
ipal waste disposal sites near the markets. Samples will 
be collected from three different locations surrounding 
the waste collection area. A sterile spatula or spoon will 
be used to collect solid waste (dark soil) to a depth of 
2.5–5.0 cm, pooled in a sterile plastic bag and mixed 
thoroughly.
Soil samples
Soil samples will be collected from within rural 
compounds/households. For households with internal 
floors made of mud-compacted soil, a sample will be 
collected from the main room of the house where most 
people usually sleep. The area should be dry and free 
of visible faeces, food or waste. In houses with concrete 
floors, we will choose an area in the yard where there is 
frequent movement of people (eg, near the kitchen or in 
front of the main household door). Using an autoclaved 
spoon, a maximum depth of about 1.5 cm below the soil 
surface will be excavated covering an area of ~30 cm2. 
Around 150 g of soil will be collected in a labelled sterile 
sample bag. Using the end of the spoon, a small scoop 
(about 0.25 g) of soil from the same area will be placed 
into a cryovial with LifeGuard solution.
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Wastewater samples
Wastewater samples will be collected from three separate 
locations of the run-off drain adjacent to the farm, house-
hold or market, and pooled together in a sterile plastic 
bottle (Nalgene, Rochester, New York). Approximately 
300 mL of water will be collected from each point by 
submerging a sterile container into the drain and trans-
ferred to a 1000 mL sterile plastic bottle.
Surface water samples
Water samples from rivers, ponds or other surface water 
downstream of periurban and rural areas will be collected 
using a sterile plastic bottle. A bottle will be filled by 
plunging downwards about 30 cm below the water surface 
and resealed tightly to prevent leakage. Particular care 
will be taken to avoid bacterial contamination inside the 
bottle or cap from sources other than the water. Sample 
bottles will be transported to the laboratory within 8 hours 
of collection.
Supply water samples
To collect water sample from tubewells, the hand pump 
will be operated continuously for 5 min. The mouth of 
the pump will then be heated by means of a gas torch, 
followed by pumping several litres of water to waste. A 
sample of water will be collected aseptically by allowing 
the water from the pump to flow directly into a sterile 
bottle. After collection, the cap of the bottle will be 
replaced carefully.
To collect samples from taps, the outside nozzle of the 
tap will be cleaned carefully. The tap will then be turned 
on full and the water allowed to run to waste for 1 min. 
The outside of the tap will be sterilised using the flame 
of a gas torch and allowed to cool by running the water 
to waste for a few seconds. The sterile sample bottle will 
be filled from a gentle flow of water and the cap placed 
on the bottle. Sample bottles will be transported to the 
laboratory within 8 hours of collection.
Human stool samples
Each study participant will be provided with a stool 
sample container and the procedure for the collection 
of samples will be explained. Field staff will pick up the 
sample container within 2 hours of collection.
For all solid and liquid samples collected in the field, 
sample bags, sample bottles and phials will be immedi-
ately placed in a cold box (4°C–8°C) and transported to 
the laboratory for analysis.
laboratory processing and analysis of human, animal and 
environmental samples
DNA will be extracted directly from samples using the 
following kits: (1) MO BIO PowerWater DNA Isolation 
Kit (MO BIO Laboratories, California, USA) for drinking 
water, surface water and wastewater samples; (2) MO BIO 
PowerSoil DNA Isolation Kit (MO BIO Laboratories) for 
mixed faecal samples from poultry pens, soil sample and 
solid waste samples; and (3) QIAamp DNA Stool Mini Kit 
(Qiagen, UK) for human stool samples, animal manure 
and poultry caecal samples. The manufacturer’s protocol 
supplied with the kit will be followed for extraction of 
DNA directly from samples.
Analysis of samples for detection and quantification of blaNDM-1 and 
blaCTX-M-1 genes by quantitative PCR assay
The amplification and detection of the blaNDM-1 and blaC-
TX-M-1 genes will be carried out in a Bio-Rad CFX96 real-time 
PCR platform by use of the TaqMan technology. Primers 
and probe sequences and PCR programs for amplifying 
blaNDM-1 and blaCTX-M-1 genes will be designed inhouse using 
publicly available sequences in the National Center for 
Biotechnology Information (NCBI) GenBank. For quan-
titation of copy number of genes, a standard curve will 
be generated using known concentrations of selected 
conserved sequence of both genes obtained from the 
NCBI GenBank. Using standard gene sequences, gene 
concentrations will be determined spectrophotometri-
cally using the NanoDrop ND 1000 instrument according 
to the manufacturer’s instructions (NanoDrop, Wilm-
ington, Delaware). DNA will be 10-fold serially diluted in 
nuclease-free water (100 ng/mL). Standard curves will be 
generated using 102–107 copies of standard DNA.
Culture of samples for E. coli resistance to third-generation 
cephalosporin or carbapenem
For human and poultry faeces, solid waste and soil 
samples, 1–5 g of sample will be weighed and dispensed 
into 9–45 mL of sterile phosphate buffered saline (PBS) 
in a sterile Falcon tube. After vortexing on high speed 
for 1 min, the suspension will be allowed to settle at room 
temperature for 15 min. From the top of the tube, 1 mL 
of suspension will be extracted and 10-fold serial dilutions 
will be made using sterile PBS. From each dilution, three 
aliquots of suspension, each of 0.1 mL, will be taken and 
inoculated onto one CHROMagar ESBL (CHROMagar, 
Paris, France), one CHROMagar KPC (Klebsiella pneu-
moniae carbapenemase) (CHROMagar) and one tryp-
tone bile x-glucuronide (TBX) agar plate (Oxoid, UK) 
following the spread plate technique. All plates will be 
incubated at 37°C for 18–24 hours. After incubation, the 
number of typical colonies of E. coli on each of the plates 
(dark pink to reddish colonies on CHROMagar ESBL 
and KPC plates and blue green colonies on the TBX 
plates) will be counted. From the ESBL and KPC plates, 
two typical colonies will be extracted and subcultured 
on MacConkey agar supplemented with cefotaxime and 
meropenem, respectively, to obtain pure culture. After 
overnight incubation of the plates at 37°C, a culture 
sweep will be taken from each plate and suspended in a 
cryovial containing tryptic soy broth (TSB) supplemented 
with 30% glycerol and stored at −80°C until further use.
For water supply samples (tap or tubewell), 2×100 mL 
of water will be passed separately through two 0.22 µm 
cellulose membrane filters and the filters will be placed in 
an upright position on three modified mTEC agar media 
(BD Difco): one without any supplementation, one 
supplemented with cefotaxime (1 mg/L) and the other 
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supplemented with meropenem (0.5 mg/L). The plates 
will be incubated at 37°C for 2 hours followed by 18 hours 
of incubation at 44°C. The remaining water samples will 
be kept at 4°C until the test is complete. If the number 
of colonies is >200 colony-forming units, then appro-
priate dilutions of the water sample will be made on the 
following day and the diluted sample will be inoculated 
on the same media and incubated as above. After incu-
bation, blue colonies, typical of E. coli, will be counted. 
At least two isolated colonies will be extracted from each 
sample plate and subcultured onto MacConkey agar plate 
supplemented with the same antibiotic and incubated 
overnight at 37°C. A culture sweep will be taken from the 
MacConkey plate and suspended in TSB media with 30% 
glycerol supplemented with the same antibiotic and kept 
at −80°C until further use.
Confirmation of E. coli using API20E
One E. coli isolate from each of the samples will be tested 
using the API20E kit (bioMérieux, France) for biochem-
ical identification. For any sample where the presumptive 
E. coli tests negative according to the API20E test, a second 
isolate will be tested in order to obtain a confirmed E. coli 
identification.
Characterisation of E. coli isolates obtained from different sources
All E. coli isolates will be tested for different ESBL and 
CARBase genes including blaCTX-M-1 and blaNDM-1. A repre-
sentative number of isolates from all environmental 
compartments will be tested for antibiotic susceptibility 
against different classes of antibiotics following the WHO 
list of critical antibiotics for human infection. Suscepti-
bility testing will be carried out according to the Clinical 
and Laboratory Standards Institute guidelines.32
E. coli isolates will be tested for genetic fingerprinting 
using random amplified polymorphic DNA (RAPD) 
analysis following the procedure described earlier.33 
Isolates will be clustered based on the RAPD banding 
pattern along with their antibiotic susceptibility patterns. 
Representative clones from each of the clusters will be 
analysed further for whole genome sequencing using 
Illumina MiSeq platform, which allows paired-end, 
long-read analysis of up to 40 DNA samples per lane. 
Data will be analysed by an automated custom bioinfor-
matics pipeline.
sample size justification
The primary outcome of the study is the prevalence of 
third-generation cephalosporin and carbapenem anti-
biotic-resistant E. coli isolates and the concentration 
of ESBL and carbapenem resistance genes in environ-
mental, human and poultry faecal samples.
As a baseline surveillance study to establish the preva-
lence of resistant bacteria and resistance genes, we have 
not made an a priori assumption based on the expected 
difference between high and low exposure groups, or 
wet and dry season prevalence rates, but this research 
has been informed by leading research in the field.4 
The sampling framework is designed to characterise 
the extent of variability in ABR by selecting 20 farms, 20 
markets and 20 rural households in each data collection 
survey (totalling 40 farms, 40 markets and 40 rural house-
holds over two surveys), which will reduce the likelihood 
of sampling bias.
data analysis
 ► Logistic regression will be carried out to determine 
whether there are significant differences in the preva-
lence of colonisation with ESBL-producing or carbap-
enem-resistant E. coli and concentrations of resistance 
genes in human groups with high and low exposure to 
environmental contamination and poultry.
 ► Generalised linear models with robust SEs will be 
used to identify predictors of colonisation with anti-
biotic-resistant E. coli in humans, such as location 
(farm, market or rural), occupational exposure, anti-
biotic use and consumption, and season (wet vs dry) 
controlling for geographical clustering.
 ► Analysis of variance (or non-parametric equiva-
lent) will be used to compare the concentrations of 
resistant bacteria and genes in upstream, wastewater 
and downstream locations, with spatial mapping of 
resistant bacteria and gene concentrations.
 ► A qualitative synthesis will be carried out on the drivers 
of antibiotic use for poultry by analysis of indepth 
interviews with farmers, domestic poultry owners and 
live-bird market workers.
 ► Logistic regression analysis will be used to compare 
human exposure-risk behaviours such as handling 
of poultry, disposal of poultry faeces, contact with 
poultry carcasses, and solid or liquid waste disposal in 
each location (markets, farms and rural villages).
EthICs And dIssEMInAtIon
Data from the project will be hosted by the Environ-
mental Information Data Centre, Centre for Ecology and 
Hydrology, in line with the data management plan. The 
results of this study will be published in peer-reviewed 
journals in the fields of global health, antimicrobial resis-
tance and the natural environment, and presented at 
national and international conferences.
The research team will follow institutional guidelines 
on the involvement of human participants and ensure 
that their rights are protected. We will invite healthy 
adults (>18 years) to participate in the study, and the study 
has been designed to be minimally invasive (collection of 
one stool sample per person) and to take as little time 
and cause as minimal inconvenience as possible (approx-
imately 20 min for an interviewer-administered question-
naire survey). Observational reports on poultry keeping, 
selling and slaughtering practices will be carried out 
in ways that avoid intruding on the daily activities of 
participants.
Participants will be informed that their involvement 
is voluntary. The purpose of the study, what would be 
involved in taking part in the study and the method 
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of collection of faecal samples from participants will 
be explained in detail on the participant information 
sheet written in Bangla, and participants will be given 
opportunities to ask questions or seek clarification. 
A written informed consent form in Bangla will be 
obtained from the participants to indicate willingness 
to take part. Participants will be informed of their right 
to withdraw from the study. To ensure anonymity, all 
survey responses and stool samples will be allocated a 
unique study identification number. No personal iden-
tifying details will be kept with either the samples or the 
survey data.
ConClusIon
This study will provide important baseline data from 
Bangladesh on the colonisation rates of healthy humans 
with antibiotic-resistant E. coli. Linking human colonisa-
tion to occupational and exposure risks from animals and 
the environment, with simultaneous assessment of resis-
tant bacteria and genes in all environmental compart-
ments, will help to identify and quantify the hot spots for 
antibiotic-resistant bacteria and antibiotic-resistant genes 
and the potential risks to human health.
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